APVO Aptevo Therapeutics Inc

Aptevo Therapeutics Inc is a biosciences company. The Company is engaged in the discovery, development, commercialization and sale of novel oncology and hematology therapeutics.

As of 11/26/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  07/20/2016
Outstanding shares:  4,898,034
Average volume:  9,766,382
Market cap:   $58,531,506
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    03835L207
ISIN:        US03835L2079
Valuation   (See tab for details)
PE ratio:   -2.19
PB ratio:   8.78
PS ratio:   5.32
Return on equity:   -304.33%
Net income %:   -201.75%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy